With the analysis among 3,268 patents, we discovered top 318 key players by total patent application. Warner-Lambert Co., Schering Corp., Boehringer Ingelheim Pharma GmbH are dominant in this area. They take 13.43% of the total patent filing.
New Jersey, United States
Patent: 159
New Jersey, United States
Patent: 152
Boehringer Ingelheim Pharma GmbH
New York, United States
Patent: 127
F. Hoffmann-La Roche Ltd.
Cambridgeshire, United Kingdom
Patent: 115
AstraZeneca Pharmaceutical Co., Ltd.
Jiangsu Sheng, China
Patent: 89
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 80
Syros Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 76
With the analysis among 46 patents, we discovered top 11 start-ups by total patent application. Histide AG, GenFleet Therapeutics (Shanghai) Co., Ltd., Carrick Therapeutics Ltd. are active in this area.
Schwyz, Switzerland
Patent: 15
GenFleet Therapeutics (Shanghai) Co., Ltd.
Shanghai Shi, China
Patent: 8
Carrick Therapeutics Ltd.
Institut National de la Santé et de la Recherche Médicale
NeoSome Life Sciences Llc
Massachusetts, United States
Patent: 4
Sumitomo Dainippon Pharma Oncology, Inc.
California, United States
Patent: 2
California, United States
Patent: 1
NiKang Therapeutics, Inc.
Delaware, United States
Patent: 1
Shenzhen Tajirui Biomedical Co. Ltd.
Guangdong Sheng, China
Patent: 1
With the analysis among related 551 patents applied in the last 5 years. We discover 129 most active companies in this area. The fast-growing Dana-Farber Cancer Institute, Inc., Syros Pharmaceuticals, Inc., Incyte Corp. take 26.50% of patent filing during this period.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 55
Syros Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 52
Delaware, United States
Patent: 39
New Jersey, United States
Patent: 20
North Carolina, United States
Patent: 16
New York, United States
Patent: 13
California, United States
Patent: 13
Gyeonggi-do, South Korea
Patent: 12
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
With the analysis among related 551 patents in last 5 years, we discover 78 new entrants. Yungjin Pharm. Co., Ltd., Kinnate Biopharma, Inc., Qurient Co., Ltd. are the most active new entrants in this area.
California, United States
Patent: 13
Gyeonggi-do, South Korea
Patent: 12
Shengke Pharmaceutical (Jiangsu) Co., Ltd.
Zhejiang Tongkang Medicine Co Ltd
Zhejiang Sheng, China
Patent: 9
Yissum Research Development Co. Ltd.
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 6
Carrick Therapeutics Ltd.
Shanghai Junshi Biosciences Co., Ltd.
Shanghai Shi, China
Patent: 5
Chengdu Saijing Biomedical Technology Co., Ltd.
Sichuan Sheng, China
Patent: 5
With the analysis among 585 patents, we discovered top 95 universities and scientific research institutions by total patent application. The University of North Carolina at Chapel Hill, Thomas Jefferson University, President & Fellows of Harvard College are dominant in this area. They take 20.51% of the total patent filing.
The University of North Carolina at Chapel Hill
North Carolina, United States
Patent: 20
Thomas Jefferson University
Pennsylvania, United States
Patent: 16
President & Fellows of Harvard College
Massachusetts, United States
Patent: 14
The Johns Hopkins University
The Salk Institute for Biological Studies
California, United States
Patent: 13
Georgia, United States
Patent: 11
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 11
Uniwersytet Przyrodniczo-Humanistyczny w Siedlcach
Mazowieckie, Poland
Patent: 10
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 7
University of Saskatchewan
Saskatchewan, Canada
Patent: 7